| 942 |
Centers for Disease Control and Prevention |
Html |
en |
What You Need to Know About Cerebral Palsy | CDC Features |
Cerebral palsy is the most common motor disability in childhood, and these children need support. Professionals who serve young children play an important role in identifying the early signs and symptoms of cerebral palsy. |
| others—that mark | 0.478193 |
| CDC | 0.432284 |
| specific cause | 0.483665 |
| Professionals | 0.455671 |
| early childhood educators | 0.551988 |
| neurological conditions | 0.471979 |
| disorders | 0.41638 |
| number | 0.41588 |
| muscles | 0.439034 |
| children | 0.703137 |
| estimate | 0.416035 |
| young children | 0.629713 |
| autism spectrum disorder | 0.679919 |
| group | 0.416386 |
| early signs | 0.636576 |
| developmental disabilities | 0.6233 |
| birth | 0.431212 |
| important role | 0.573438 |
| symptoms | 0.479175 |
| exact symptoms | 0.476031 |
| local early intervention | 0.53025 |
| appropriate services | 0.472053 |
| person | 0.480149 |
| support | 0.437616 |
|
| ADDM CP Network | 0.632112 |
| recent report | 0.48306 |
| United States | 0.549579 |
| diverse communities | 0.476805 |
| 8-year-old children | 0.493929 |
| daily activities | 0.478289 |
| co-occurring conditions | 0.475526 |
| supports | 0.432922 |
| spastic CP | 0.574326 |
| local school | 0.468966 |
| Monitoring | 0.415905 |
| characteristics | 0.415874 |
| cases | 0.416302 |
| common motor disability | 0.734148 |
| posture | 0.416886 |
| movement milestones | 0.471649 |
| abnormal brain development | 0.547576 |
| families | 0.448455 |
| CP | 0.867247 |
| pediatricians | 0.4188 |
| valuable resource | 0.478803 |
| cerebral palsy | 0.974339 |
| multiple communities | 0.480091 |
| time | 0.415314 |
|
CLICK HERE |
| 1118 |
Centers for Disease Control and Prevention |
Html |
en |
Trends in Foodborne Illness in the United States, 2013 | CDC Features |
The nation’s food safety grades are out and the results are mixed. CDC’s annual report shows that foodborne infections continue to be an important public health problem in the United States. More can be done. |
| CDC.gov Current Features | 0.906892 |
|
|
CLICK HERE |
| 5365 |
Centers for Disease Control and Prevention |
Html |
en |
Report Finds Global Smokers Consider Quitting due to Graphic Health Warnings on Packages - Press Release: May 26, 2011 |
Report Finds Global Smokers Consider Quitting due to Graphic Health Warnings on Packages |
| tobacco product packages | 0.75055 |
| Mortality Weekly Report | 0.646892 |
| CDC Foundation | 0.520783 |
| adult usage | 0.524155 |
| international partners | 0.520965 |
| package warning | 0.542571 |
| World No Tobacco | 0.756965 |
| urgent action | 0.519934 |
| tobacco | 0.898975 |
| representative household survey | 0.590639 |
| public acceptance | 0.520505 |
| Hopkins Bloomberg School | 0.596194 |
| national governments | 0.518477 |
| Reduce Tobacco | 0.65418 |
| World Health Organization | 0.993101 |
| comprehensive tobacco control | 0.836638 |
| pictorial warnings | 0.784008 |
| MPOWER package | 0.540578 |
| countries | 0.611383 |
| Tobacco Day—an | 0.667379 |
| Effective warning labels | 0.658231 |
| World Lung Foundation | 0.602118 |
| mass media campaigns | 0.597118 |
| global public health | 0.648075 |
| Tobacco Free Kids | 0.741601 |
|
| 14-nation study | 0.533061 |
| tobacco-related health information | 0.641508 |
| CDC director Thomas | 0.640025 |
| Russian Federation | 0.626485 |
| malaria combined—and | 0.519073 |
| graphic health warnings | 0.729273 |
| tobacco advertising | 0.67 |
| percent | 0.648219 |
| electronic data collection | 0.622445 |
| face-to-face personal interviews | 0.624282 |
| additional countries | 0.540034 |
| public awareness | 0.52168 |
| tobacco initiation | 0.670209 |
| Tobacco Free Initiative | 0.747287 |
| global tobacco | 0.679114 |
| Global Adult Tobacco | 0.804341 |
| impact cost-effective initiatives | 0.597652 |
| R. Frieden | 0.526599 |
| health warnings | 0.822697 |
| World Health Assembly | 0.646442 |
| cigarette packages | 0.530572 |
| prompt smokers | 0.536251 |
| GATS | 0.513985 |
| package warnings | 0.711812 |
|
CLICK HERE |
| 7974 |
Centers for Disease Control and Prevention |
Html |
en |
Critical Congenital Heart Defects in the United States - NCBDDD |
null |
| CCHD main screening | 0.434218 |
| specific CCHDs | 0.343097 |
| National Birth Defects | 0.514843 |
| Pregnancy termination rates | 0.359435 |
| Disease Control | 0.340689 |
| children | 0.357598 |
| care facilities | 0.358838 |
| Heart Defects Targeted | 0.594526 |
| training health care | 0.361515 |
| CCHD screening | 0.467624 |
| tricuspid valve atresia | 0.36484 |
| pulmonary venous return | 0.362592 |
| normal screening result | 0.416491 |
| Defects Monitoring Programs | 0.536393 |
| different states | 0.339989 |
| live births | 0.362003 |
| Congenital Heart Defects | 0.602865 |
| simple bedside test | 0.366608 |
| specific CCHD | 0.341714 |
| main screening targets | 0.475356 |
| Molecular Teratology. | 0.357143 |
| newborn screening | 0.686175 |
| defects surveillance programs | 0.665835 |
| Recommended Uniform Screening | 0.472029 |
| Birth Defects Monitoring | 0.546697 |
|
| Essential Public Health | 0.425369 |
| U.S. Recommended Uniform | 0.364777 |
| newborn screening programs | 0.438344 |
| United States | 0.405326 |
| babies | 0.351546 |
| Birth Defects Research | 0.571803 |
| way programs | 0.344973 |
| birth defects surveillance | 0.670514 |
| Public Health Roles | 0.425796 |
| health services | 0.352613 |
| critical congenital heart | 0.789819 |
| congenital heart disease | 0.487833 |
| CCHDs | 0.428054 |
| Pulse Oximetry Screening | 0.563436 |
| Uniform Screening Panel | 0.471899 |
| 50 states | 0.34081 |
| heart syndrome | 0.342317 |
| Population-based Birth Defects | 0.612595 |
| birth defects | 0.961121 |
| certain medical conditions | 0.369692 |
| birth defects data | 0.659331 |
| new U.S. data | 0.379031 |
| CCHD newborn screening | 0.442181 |
| information | 0.357295 |
|
CLICK HERE |
| 9869 |
Centers for Disease Control and Prevention |
Html |
en |
Travelers' Health - Division of Global Migration and Quarantine (DGMQ) - NCEZID |
null |
| vaccine recommendations | 0.554088 |
| monitors data sources | 0.361366 |
| travel-related disease information | 0.447998 |
| travel health risks | 0.519051 |
| health alerts | 0.360099 |
| Uses GeoSentinel data | 0.363324 |
| Health Branch | 0.470379 |
| travel-related health information | 0.497666 |
| monitoring travel-related illnesses | 0.392662 |
| emergency response workers | 0.383244 |
| U.S. yellow fever | 0.551798 |
| globally mobile populations | 0.362015 |
| International Travel | 0.423698 |
| yellow fever vaccine | 0.999511 |
| health care providers | 0.960775 |
| CDC Health Information | 0.636337 |
| Conducts audience research | 0.36037 |
| travel health advice | 0.533034 |
| pre-travel health care | 0.479693 |
| global emergency response | 0.404969 |
| travel health messages | 0.500451 |
| Yellow Book | 0.536849 |
| global public health | 0.512694 |
| health communication | 0.452518 |
|
| yellow fever vaccination | 0.552846 |
| Education Team informs | 0.379702 |
| health threats | 0.385517 |
| disease outbreaks | 0.396242 |
| travel medicine | 0.489279 |
| travel medicine clinics | 0.432581 |
| special needs travelers | 0.488295 |
| travel health | 0.676438 |
| destination-specific recommendations | 0.344183 |
| Oxford University Press | 0.380147 |
| GeoSentinel Network Surveillance | 0.360851 |
| U.S. residents | 0.326071 |
| government travel health | 0.498333 |
| travel health guidance | 0.497286 |
| fever regulatory responsibilities | 0.439731 |
| U.S. travel medicine | 0.460291 |
| Professionals Advising Travelers | 0.486248 |
| travel notices | 0.34725 |
| tropical medicine clinics | 0.368266 |
| H1N1 influenza pandemic | 0.382493 |
| international travelers | 0.436457 |
| travel health recommendations | 0.641332 |
| global yellow fever | 0.54863 |
| fever vaccine safety | 0.498233 |
|
CLICK HERE |
| 10067 |
Centers for Disease Control and Prevention |
Html |
en |
NIOSH Program Portfolio : Immune Diseases : Goals |
The mission of the NIOSH research program for Immune, Dermal & Infectious Diseases is to eliminate occupational injuries, illnesses, and fatalities among workers in these industries through a focused program of research and prevention. Primary efforts are focused on hazard identification since when potential hazards are recognized, work-related dermal and immune diseases can often be prevented or their effects minimized. |
| occupational asthma | 0.673934 |
| current governmental approaches | 0.672232 |
| effective prevention strategies | 0.654356 |
| significant health risks | 0.690684 |
| normal immune function | 0.90514 |
| risk assessment strategies | 0.663448 |
| altered immune function | 0.744156 |
| immune responses | 0.695158 |
| indoor air chemicals | 0.669711 |
| sector programs | 0.791804 |
| NIOSH sector program | 0.78076 |
| occupational allergen exposures | 0.776647 |
| NIOSH Sector Programs | 0.788906 |
| potential indoor air | 0.65678 |
| infectious cough-generated aerosols | 0.652851 |
| specific allergic mediators | 0.670244 |
| allergic skin sensitization | 0.688585 |
| allergic rhinitis | 0.698576 |
| Intermediate Goal | 0.921013 |
| safer exposure levels | 0.66935 |
| health effects | 0.902367 |
| immune diseases goal | 0.751273 |
| Program Assessment Rating | 0.681504 |
| mold-contaminated workplaces | 0.674902 |
| Provide scientific data | 0.746807 |
|
| immune parameters | 0.669812 |
| NIOSH Immune | 0.738999 |
| adverse health outcomes | 0.683604 |
| cross-sector programs | 0.680975 |
| adverse health effects | 0.677532 |
| Cross Sector programs | 0.705106 |
| NORA Sector Council | 0.680752 |
| program goals | 0.660999 |
| immune function | 0.913089 |
| NIOSH Program Portfolio | 0.761671 |
| associated pathophysiological disorders | 0.661336 |
| certain occupational chemicals | 0.716341 |
| Fishing Program goal | 0.702708 |
| fungal exposure | 0.660668 |
| immune abnormalities | 0.7581 |
| occupational exposures | 0.751568 |
| occupational allergens | 0.725208 |
| clinical disease | 0.670005 |
| indoor air | 0.763389 |
| exposure-related health effects | 0.676322 |
| significant health effects | 0.671699 |
| certain work environments | 0.672218 |
| various sectors | 0.662471 |
| health risks | 0.737673 |
|
CLICK HERE |
| 10463 |
Centers for Disease Control and Prevention |
Html |
en |
Email Updates: July 1, 2013'Clinicians Outreach and Communication Activity (COCA) |
CDC Clinician Outreach and Communication Activity (COCA). Providing clinicians the most current and reliable information on emerging public health threats, such as pandemics, natural disasters, and bioterrorism. |
| injury data collection | 0.772013 |
| CDC | 0.895655 |
| Involving Inhalation Anthrax | 0.770935 |
| Emergency Preparedness | 0.788271 |
| Respiratory Syndrome Coronavirus | 0.782788 |
| FDA Safety Information | 0.767061 |
| emergency risk communication | 0.925078 |
| state level response | 0.796992 |
| effective response | 0.706826 |
| Previous COCA Conference | 0.792537 |
| – (CDC) | 0.788089 |
| new avian influenza | 0.774919 |
| CDC Science Clips | 0.880885 |
| CDC Influenza Division | 0.86601 |
| new H7N9 virus | 0.7674 |
| important safety information | 0.763668 |
| alternative treatment sites | 0.771022 |
| racial/ethnic minority groups | 0.760038 |
| health care providers | 0.869685 |
| Weekly Flu View | 0.765101 |
| Free CE credit/contact | 0.757319 |
| human medical products | 0.752516 |
| disaster preparedness | 0.716425 |
| health messaging | 0.718014 |
|
| exciting new content | 0.762796 |
| play important roles | 0.775394 |
| Current Travel Warnings | 0.751791 |
| seasonal flu | 0.743678 |
| Event Reporting Program | 0.753214 |
| State Health Departments | 0.808596 |
| East Respiratory Syndrome | 0.878547 |
| pre-hospital transport decision | 0.765607 |
| respiratory illness | 0.764727 |
| COCA Email Update | 0.818941 |
| public health community | 0.806541 |
| Public Health Practice | 0.803791 |
| public health | 0.837018 |
| Risk Communication Course | 0.764974 |
| Specific Hazards preparedness | 0.783678 |
| Middle East Respiratory | 0.878583 |
| public opinion polls | 0.772598 |
| in-person training centers | 0.758331 |
| Eastern Time | 0.788664 |
| FoodSafety.gov Reports FDA | 0.765252 |
| weekly influenza surveillance | 0.761273 |
| severe respiratory illness | 0.760727 |
| USDA Food Recalls | 0.750749 |
| Response Training Resources | 0.782253 |
|
CLICK HERE |
| 11157 |
Centers for Disease Control and Prevention |
Html |
en |
Additional Transplant Related Organizations |
CDC – Information to help make organ and tissue transplants the highest quality possible so that recipients have the best outcomes. |
| MPEG | 0.741242 |
| site | 0.541063 |
| PDF | 0.544429 |
|
|
CLICK HERE |
| 14047 |
Centers for Disease Control and Prevention |
Image |
null |
E-cigarette Ads and Youth Infographics |
null |
|
|
CLICK HERE |
| 15996 |
Centers for Disease Control and Prevention |
Html |
en |
Collecting & Submitting Fetal Tissue Specimens for Zika Virus Testing | Zika virus |
Information on Zika virus. Provided by the U.S. Centers for Disease Control and Prevention. |
| Pathologic Evaluation | 0.388427 |
| infant death | 0.390008 |
| formalin-fixed wet tissues | 0.56903 |
| CDC Form | 0.428563 |
| wet tissues | 0.614442 |
| final surgical pathology | 0.405112 |
| fetal membranes | 0.458394 |
| Body Fluid Specimens | 0.440722 |
| zika virus testing | 0.941554 |
| gestational age | 0.386268 |
| Possible Infectious Etiologies | 0.384397 |
| test results | 0.381764 |
| formalin-fixed tissues | 0.455163 |
| tissues | 0.64315 |
| early pregnancy loss/miscarriage | 0.378511 |
| formalin-fixed specimens | 0.389394 |
| Zika biosafety guidelines | 0.399771 |
| pathology reports results | 0.395542 |
| Test Order Code | 0.380785 |
| fixed tissues | 0.477854 |
| specimen identification numbers | 0.398273 |
| Diseases Pathology Branch | 0.400793 |
| specimen submission paperwork | 0.399758 |
| Zika virus immunohistochemistry | 0.436753 |
| body fluid analysis | 0.386069 |
|
| placental disk | 0.406696 |
| maternal Zika virus | 0.458528 |
| surgical pathology | 0.515407 |
| Zika testing results | 0.406816 |
| possible zika virus | 0.520146 |
| fetal tissues | 0.502489 |
| infant Zika virus | 0.478557 |
| formalin-fixed paraffin-embedded tissue | 0.475008 |
| placental tissues | 0.474188 |
| Zika virus infection | 0.443877 |
| infant autopsy report | 0.423751 |
| local health department | 0.391756 |
| Health Care Providers | 0.392259 |
| paraffin-embedded tissue blocks | 0.470939 |
| infant autopsy tissue | 0.472396 |
| umbilical cord | 0.387281 |
| tissue specimens | 0.454633 |
| infant autopsy tissues | 0.627955 |
| frozen tissues | 0.459001 |
| specimens | 0.47701 |
| formalin-fixed paraffin-embedded tissues | 0.49478 |
| birth anthropometric measurements | 0.380022 |
| healthcare provider | 0.381483 |
| Fetal loss | 0.408667 |
|
CLICK HERE |